Focus Stocks
New Ratings
Published on Thursday, 14 June 2012 09:04 Written by Danny Miller
New York, June 14th (TradersHuddle.com) – Following are some of the new analyst ratings before the market open.
Research Firms Initiate:
Apricus Biosciences (NASDAQ: APRI) was initiated with Outperform at JMP Securities.
EV Energy Partners, L.P. (NASDAQ: EVEP) was initiated with a Neutral at Credit Suisse.
Idenix Pharmaceuticals (NASDAQ: IDIX) was initiated with a Buy and a target price of $11 at Maxim Group.
Ignite Restaurant Group (NASDAQ: IRG) was initiated with Outperform at Raymond James and with a Buy and a target price of $22 at KeyBanc Capital Markets.
Immunogen (NASDAQ: IMGN) was initiated with a Hold and a target price of $15 at Cantor Fitzgerald.
Tesla Motors (NASDAQ: TSLA) was initiated with a Buy at Lazard.
Ventrus Biosciences (NASDAQ: VTUS) was initiated with a Buy and a target price of $30 at Brean Murray.
Xenoport (NASDAQ: XNPT) was initiated with Outperform at Wells Fargo.
Related Articles
- Idenix Announces Data Presentation at the 48th Annual Meeting of the European Association for the Study of the Liver (EASL)
- Apricus Biosciences Announces Sale of Non-Core Assets
- ImmunoGen, Inc. to Ring The NASDAQ Stock Market Closing Bell
- Idenix Pharmaceuticals Announces Decision by the United States Patent and Trademark Office Patent Trial and Appeal Board in the First Phase of the Interference
- Apricus Biosciences Announces 2012 Year End Financial Results Conference Call
- Apricus Biosciences Announces Ceasing of Financing of French Subsidiaries
- Apricus Biosciences to Present at the 25th Annual ROTH Conference
- Apricus Biosciences to Present at BIO-Europe Spring 2013
- Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
- Idenix Pharmaceuticals Reports Fourth Quarter and Year Ended 2012 Financial Results
Related Partner Headlines
- EV Energy Partner LP Stock Downgraded (EVEP) - TheStreet.com
- UPDATE: Citigroup Cuts PT to $68.50 on EV Energy Partners Following Q3 Results - Benzinga
- UPDATE: Stifel Nicolaus Initiates EV Energy Partners at Buy on Distribution Outlook - Benzinga
- UPDATE: Citigroup Raises PT to $72.50 on EV Energy Partners on Valuation - Benzinga
- Apricus Biosciences Announces Intent to File NDS for MycoVa in Canada - Benzinga
- FDA Requested Additional Data Related to Idenix Pharmaceuticals IDX184 and IDX19368 -8K - Benzinga
- Apricus Biosciences Subsidiary NexMed and Takeda Pharmaceuticals Sign Agreement to Market Vitaros in UK - Benzinga
- Three Oil & Gas Stocks Analysts Are Keen On (NGL, HNR, EVEP) - Benzinga
- UPDATE: Oppenheimer Maintains Idenix Pharmaceuticals at Perform Following Clinical Hold on IDX19368 - Benzinga
- UPDATE: Wedbush Lowers PT to $9 on Idenix Pharmaceuticals; IDX184 on Clinical Hold - Benzinga
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
